Barron's article makes positive comments on Onyx Pharmaceuticals (Nasdaq: ONXX), saying current valuation looks cheap, and highlights the company's Nexavar ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE